Since January 2021, he has been responsible for the negotiations of innovative, Asia-sourced opportunities to strengthen Roche's pipeline. Harm-Jan is based in Shanghai and is a member of the Leadership Team of Roche Corporate Business Development. He obtained his master's degree from Wageningen University, the Netherlands, and received his PhD degree from the Faculty of Medicine, Nagoya University in Nagoya, Japan. He also received his MBA from the Rotterdam School of Management. In 2003, he joined Kyorin Pharmaceuticals as Head of BD Europe. He spent most of his career at Merck Healthcare KGaA, serving for over 15 years in various positions, including business development, clinical development, and alliance management.